These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 34424751)
1. α-Galactosylceramide-Reactive NKT Cells Increase IgG1 Class Switch against a Clostridioides difficile Polysaccharide Antigen and Enhance Immunity against a Live Pathogen Challenge. Lang GA; Shrestha B; Amadou Amani S; Shadid TM; Ballard JD; Lang ML Infect Immun; 2021 Oct; 89(11):e0043821. PubMed ID: 34424751 [TBL] [Abstract][Full Text] [Related]
2. Use of a Lang GA; Norman K; Amadou Amani S; Shadid TM; Ballard JD; Lang ML Front Immunol; 2021; 12():818734. PubMed ID: 35095921 [TBL] [Abstract][Full Text] [Related]
3. Immunization-Expanded NKT Follicular Helper Cells Drive IgG1 Isotype Switch against an Exogenous T-Independent Polysaccharide but Do Not Promote Recall Responses. Lang GA; Amadou Amani S; Quinn JL; Axtell RC; Lang ML Immunohorizons; 2019 Mar; 3(3):88-93. PubMed ID: 31342012 [TBL] [Abstract][Full Text] [Related]
4. Coordination between T helper cells, iNKT cells, and their follicular helper subsets in the humoral immune response against Clostridium difficile toxin B. Rampuria P; Lang GA; Devera TS; Gilmore C; Ballard JD; Lang ML J Leukoc Biol; 2017 Feb; 101(2):567-576. PubMed ID: 27566831 [TBL] [Abstract][Full Text] [Related]
5. Regulation of anthrax toxin-specific antibody titers by natural killer T cell-derived IL-4 and IFNγ. Devera TS; Joshi SK; Aye LM; Lang GA; Ballard JD; Lang ML PLoS One; 2011; 6(8):e23817. PubMed ID: 21858226 [TBL] [Abstract][Full Text] [Related]
6. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner. Lang GA; Exley MA; Lang ML Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697 [TBL] [Abstract][Full Text] [Related]
7. CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies. Devera TS; Aye LM; Lang GA; Joshi SK; Ballard JD; Lang ML Infect Immun; 2010 Apr; 78(4):1610-7. PubMed ID: 20123711 [TBL] [Abstract][Full Text] [Related]
8. Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity. Romano MR; Leuzzi R; Cappelletti E; Tontini M; Nilo A; Proietti D; Berti F; Costantino P; Adamo R; Scarselli M Toxins (Basel); 2014 Apr; 6(4):1385-96. PubMed ID: 24759173 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus. Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096 [TBL] [Abstract][Full Text] [Related]
10. Glycolipid-Containing Nanoparticle Vaccine Engages Invariant NKT Cells to Enhance Humoral Protection against Systemic Bacterial Infection but Abrogates T-Independent Vaccine Responses. Shute T; Amiel E; Alam N; Yates JL; Mohrs K; Dudley E; Salas B; Mesa C; Serrata A; Angel D; Vincent BK; Weyers A; Lanthier PA; Vomhof-Dekrey E; Fromme R; Laughlin M; Durham O; Miao J; Shipp D; Linhardt RJ; Nash K; Leadbetter EA J Immunol; 2021 Apr; 206(8):1806-1816. PubMed ID: 33811104 [TBL] [Abstract][Full Text] [Related]
11. BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand. Shah HB; Joshi SK; Rampuria P; Devera TS; Lang GA; Stohl W; Lang ML J Immunol; 2013 Aug; 191(3):1154-63. PubMed ID: 23797666 [TBL] [Abstract][Full Text] [Related]
12. Reduction of CD1d expression in vivo minimally affects NKT-enhanced antibody production but boosts B-cell memory. Lang GA; Johnson AM; Devera TS; Joshi SK; Lang ML Int Immunol; 2011 Apr; 23(4):251-60. PubMed ID: 21398691 [TBL] [Abstract][Full Text] [Related]
13. Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides. Bai L; Deng S; Reboulet R; Mathew R; Teyton L; Savage PB; Bendelac A Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16097-102. PubMed ID: 24043771 [TBL] [Abstract][Full Text] [Related]
14. Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells. Venkataswamy MM; Ng TW; Kharkwal SS; Carreño LJ; Johnson AJ; Kunnath-Velayudhan S; Liu Z; Bittman R; Jervis PJ; Cox LR; Besra GS; Wen X; Yuan W; Tsuji M; Li X; Ho DD; Chan J; Lee S; Frothingham R; Haynes BF; Panas MW; Gillard GO; Sixsmith JD; Korioth-Schmitz B; Schmitz JE; Larsen MH; Jacobs WR; Porcelli SA PLoS One; 2014; 9(9):e108383. PubMed ID: 25255287 [TBL] [Abstract][Full Text] [Related]
15. The Murine Neonatal Fc Receptor Is Required for Transport of Immunization-Induced C. difficile-Specific IgG to the Gut and Protection against Disease but Does Not Affect Disease Susceptibility. Amadou Amani S; Lang GA; Ballard JD; Lang ML Infect Immun; 2021 Sep; 89(10):e0027421. PubMed ID: 34097471 [TBL] [Abstract][Full Text] [Related]
16. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen. Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017 [TBL] [Abstract][Full Text] [Related]
17. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers. Singh AK; Rhost S; Löfbom L; Cardell SL Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185 [TBL] [Abstract][Full Text] [Related]